Home > PJ (current issue) > Letters | Search

Return to PJ Online Home Page

The Pharmaceutical Journal
Vol 270 No 7252 p792
7 June 2003

This page
Reprint
Photocopy

   

PDF* 90K

Letters

  SGM
  New Charter
  CD prescribing
  Asthma
  CFC-free inhaling
  Remuneration
  Branding
  Pharmacy closures
  Yellow cards
  Patient packs
  Penicillin
  The Society


Letters to the Editor

  * PDF files on PJ Online require Acrobat Reader 4 or later.

Branding

There should be one brand name for one drug

From Mr R. A. Lowe, MRPharmS

I refer to the advertisement on the back of The Pharmaceutical Journal of 17 May for the latest over-the-counter medicines from Pfizer Consumer Healthcare. It appears that the Benadryl brand name is the most important piece of information on the packaging. If one looks closely, one can see that Benadryl Allergy Relief capsules contain acrivastine, whereas Benadryl Allergy oral solution contains cetirizine.

Surely one brand name should be associated with the approved name of only one particular drug?

Robert Lowe
Wymondham, Norfolk

Send your letter to The Editor

Previous Topic (Remuneration)
Next Topic (Pharmacy closures)

Back to Top


Home | Journals | News | Notice-board | Search | Jobs  Classifieds | Site Map | Contact us

©The Pharmaceutical Journal